Antihypertensive Drugs for Aortic Stenosis
Links shared publicly online about this topic
Osteoporosis drugs hint at slowing aortic-stenosis progression
theheart.org — “Bisphosphonates and other drugs that increase bone-mineral density may have potential in a disorder for which surgery is currently the only proven therapy, suggests a small observational study.” View full resource at theheart.org
Most Recently Shared on July 20, 2009 at 6:13 pm By:
heartwire: Osteoporosis drugs hint at slowing aortic-stenosis progression http://bit.ly/NpGUQ
New Procedure for Aortic Valve Replacement Looks Promising - Drugs.com MedNews
drugs.com — “For patients who are too sick to withstand surgery to treat a narrowed aortic valve, a new and less invasive heart procedure might keep them alive, researchers” View full resource at drugs.com
Most Recently Shared on September 22, 2010 at 10:14 pm By:
Drugs and Devices OW OW Health
New Procedure for Aortic Valve Replacement Looks Promising: WEDNESDAY, Sept. 22 -- For patients who are too s... http://bit.ly/abveWD #drug
Gender Differences Seen After Aortic Valve Surgery - Drugs.com MedNews
drugs.com — “Genetic differences may explain why enlarged hearts shrink faster in women than in men following aortic valve replacement, say researchers. Heart enlargement oc” View full resource at drugs.com
Most Recently Shared on September 14, 2010 at 9:08 pm By:
Drugs and Devices OW OW Health
Gender Differences Seen After Aortic Valve Surgery: TUESDAY, Sept. 14 -- Genetic differences may explain why ... http://bit.ly/bPlwlC #drug
Medtronic Clinical Trial Receives FDA Approval To Evaluate New CoreValve(R) System For Aortic Valve Implantation
medicalnewstoday.com — “Medtronic, Inc. (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) conditional approval for its Investigational Device Exemption (IDE) application and pivotal clinical trial proto” View full resource at medicalnewstoday.com
Most Recently Shared on October 17, 2010 at 10:22 am By:
MNT Cardiovascular Health News
Medtronic Clinical Trial Receives FDA Approval To Evaluate New CoreValve(R) System For Aortic Valve Implantation http://mnt.to/3LjV
Best medical treatment for a symptomatic carotid artery stenosis -- Authors' reply : The Lancet
thelancet.com — “Best medical treatment for a symptomatic carotid artery stenosis -- Authors' reply. By - Alison Halliday, Richard Peto, on behalf of the ACST collaborators” View full resource at thelancet.com
Most Recently Shared on January 9, 2011 at 11:24 am By:
[Correspondence] Best medical treatment for a symptomatic carotid artery stenosis – Authors' reply: For patien... http://bit.ly/f133qm
FDA Approves First Artificial Aortic Heart Valve Placed Without Open-Heart Surgery
medicalnewstoday.com — “The U.S. Food and Drug Administration approved the first artificial heart valve that can replace an aortic heart valve damaged by senile aortic valve stenosis without open-heart surgery.” View full resource at medicalnewstoday.com
Most Recently Shared on November 4, 2011 at 10:05 am By:
MNT Drug Approvals Health News
FDA Approves First Artificial Aortic Heart Valve Placed Without Open-Heart Surgery http://t.co/5k8fpBsH #regulatory
FDA Releases Briefing Documents for Advisory Panel on the Edwards Sapien Transcatheter Aortic Valve Implant - Larry Husten - Cardiobrief - Forbes
blogs.forbes.com — “The FDA has posted the briefing documents for the much-anticipated meeting on Wednesday of the Circulatory Systems Devices Panel for the Edwards Sapien transcatheter heart valve system in patients with severe aortic stenosis who are not eligible for surgical valve replacement, as studied in the PARTNER B trial. Overall the [...]” View full resource at blogs.forbes.com
Most Recently Shared on July 18, 2011 at 2:14 pm By:
Drugs and Devices OW OW Health
FDA Releases Briefing Documents for Advisory Panel on the Edwards Sapien Transcatheter Aortic Valve Imp... http://onforb.es/qBzWxJ #drug
Medtronic Clinical Trial Receives FDA Approval To Evaluate New CoreValve(R) System For Aortic Valve Implantation - QualityPoint Technologies
qualitypointtech.net — “Medtronic, Inc. (NYSE: MDT) today announced U.S. Food and Drug Administration (FDA) conditional approval for its Investigational Device Exemption (IDE) application and pivotal clinical trial protocol to begin evaluating the Medtronic CoreValve System for transcatheter aortic valve implantation (TAVI). The CoreValve System is designed to provide a minimally invasive, non-surgical treatment option for patients with symptomatic, severe aortic stenosis who are at high risk, or are ineligible, for op” View full resource at qualitypointtech.net
Most Recently Shared on October 17, 2010 at 4:33 pm By:
Medtronic Clinical Trial Receives FDA Approval To Evaluate New CoreValve(R) System For Aortic Valve Implantation: ... http://bit.ly/bea8CT
Drug may treat one form of heart disease - UPI.com
upi.com — “A drug could replace surgery and reduce risk of mortality in people with the heart disease calcific aortic stenosis, Canadian researchers say.” View full resource at upi.com
Most Recently Shared on October 26, 2011 at 5:30 am By:
Drug may treat one form of heart disease: VANCOUVER, British Columbia, Oct. 26 (UPI) -- A drug could replace sur... http://t.co/KsHCypqg
Follow-Up to the August 2008 Early Communication About an Ongoing Safety Review of Ezetimibe/Simvastatin (marketed as Vytorin), Simvastatin (marketed as Zocor) and Ezetimibe (marketed as Zetia) - FDA Investigates a Report from the SEAS Trial
fda.gov — “In august 2008, the u.s. food and drug administration (fda) issued an early communication describing a possible association between the use of vytorin – a combination of simvastatin (zocor) and ezetimibe (zetia) – and an increased risk of cancer and cancer-related death compared to placebo.” View full resource at fda.gov
Most Recently Shared on December 22, 2009 at 4:31 pm By:
eyeonfda Pharma and Health Lawyer
RT @FDA_Drug_Info: Follow-Up to the Aug. 2008 Early Communication on Vytorin, Zetia, Zocor and the SEAS Trial. http://bit.ly/FU_SEAS
Double duty for blood pressure drugs: how they could revolutionize how we treat valve disease
eurekalert.org — “A type of medication known as angiotensin-receptor blockers could reduce risk of mortality in people with a heart disease called calcific aortic stenosis (AS) by 30 per cent over an eight-year period, Heart and Stroke Foundation researcher Dr. Philippe Pibarot told delegates at the Canadian Cardiovascular Congress. The condition is currently managed with open heart surgery.” View full resource at eurekalert.org
Most Recently Shared on October 25, 2011 at 5:23 am By:
Double duty for blood pressure drugs: how they could revolutionize how we treat valve disease: ( Heart and Strok... http://t.co/uvj0fZ3u
Med Student Medical News about Renal Artery
mdlinx.com — “Revascularization Versus Medical Therapy for Renal Artery Stenosis: Antihypertensive Drugs and Renal Outcome” View full resource at mdlinx.com
Most Recently Shared on June 16, 2010 at 11:41 pm By:
Sandeep Pulim MD Doctor, Health Communicator, and Physician
Dr Rosario Cianci just commented on: Revascularization Versus Medical Therapy for Renal Artery Sten... http://bit.ly/bbfGvD #author #mdlinx
Sapien Transcatheter Heart Valve Receives Strong Support from FDA Advisory Panel - Larry Husten - Cardiobrief - Forbes
blogs.forbes.com — “The FDA Circulatory Systems Devices Panel has given a strong vote of support in favor of the Sapien Transcatheter Heart Valve (THV) for use in patients with inoperable severe aortic stenosis and with no co-morbidities precluding benefit from correction of the aortic stenosis. By large majorities, the panel [...]” View full resource at blogs.forbes.com
Most Recently Shared on July 21, 2011 at 12:06 am By:
Drugs and Devices OW OW Health
Sapien Transcatheter Heart Valve Receives Strong Support from FDA Advisory Panel: The FDA Circulatory S... http://onforb.es/plj9Zb #drug
Edwards Lifescience receives FDA approval for Sapien Transcatheter Heart Valve
news-medical.net — “The U.S. Food and Drug Administration today approved the first artificial heart valve that can replace an aortic heart valve damaged by senile aortic valve stenosis without open-heart surgery.” View full resource at news-medical.net
Most Recently Shared on November 3, 2011 at 6:32 am By:
Edwards Lifescience receives FDA approval for Sapien Transcatheter Heart Valve: The U.S. Food and Drug Administr... http://t.co/o3PaE0fh
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
Shelley Wood
Managing editor for heartwire on theheart.org--the most authoritative, balanced, and insightful cardiovascular disease news online. http://is.gd/nHJ4
-
Drugs and Devices OW
Organizing drug and medical device resources shared by health experts, advocates, and organizations into WisdomCards.
-
Drugs and Devices OW
Organizing drug and medical device resources shared by health experts, advocates, and organizations into WisdomCards.
Advertisement
